Bessemer Venture Partners

Activity from announced rounds

Activity in this selectionOct 15, 2026 · Biotech · Sep 16, 2026

Bessemer Venture Partners has dedicated seed, early-stage and growth practices, investing across enterprise software, developer technology, fintech, healthcare and deep technology.

Its Roadmaps set out the investment team’s sector theses, giving founders a way to understand how Bessemer evaluates emerging markets before approaching a partner. Atlas publishes company-building research alongside those investment perspectives.

Portfolio resources include talent searches, candidate introductions and compensation benchmarks, as well as operating advisers, commercial connections and peer forums. The combination is relevant when a startup needs both a sector investor and help building its first executive or commercial organisation.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$135M
1 disclosed · full round size, not this investor’s share

By stage

Series B1

By primary sector

Biotech1

By country

United States1

Rounds

1 in this selection
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant